Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Raul H. Bordenave"'
Autor:
Emilio Batagelj, Norma Alejandra Chasseing, Leandro Marcelo Martinez, Ana Rodriguez Villafañe, Hosoon Choi, Vivian Labovsky, Federico Dimase, Leonardo Feldman, Valeria Beatriz Fernández Vallone, Raul H. Bordenave, Erica Leonor Hofer
Publikováno v:
Clinical & Experimental Metastasis. 31:213-232
Bone metastasis is an incurable complication of breast cancer affecting 70-80 % of advanced patients. It is a multistep process that includes tumour cell mobilisation, intravasation, survival in the circulation, extravasation, migration and prolifera
Autor:
Carlos Gabriel Belloc, Leandro Feldman, Valeria Beatriz Fernández Vallone, Alba Elizabeth Honegger, Raul H. Bordenave, Vivian Labovsky, Vincent F. La Russa, Eduardo Bullorsky, Huei Chi Wen, Norma Alejandra Chasseing, Erica Leonor Hofer
Publikováno v:
Stem Cells and Development. 19:359-370
We have shown that bone marrow (BM) from untreated advanced lung and breast cancer patients (LCP and BCP) have a reduced number of colony-forming unit fibroblasts (CFU-Fs) or mesenchymal stem cells (MSCs). Factors that regulate the proliferation and
Autor:
Eduardo O. Bullorsky, Lia S. Rumi, Norma B. Diaz, Norma Alejandra Chasseing, German R. Stemmelin, Raul H. Bordenave
Publikováno v:
Cancer. 80:1914-1919
BACKGROUND Although alterations of the bone marrow (BM) fibroblast colony-forming cells are involved in the development of diverse hematologic disorders, these progenitors still have not been well characterized in patients with solid tumors. METHODS
Autor:
Raul H. Bordenave, Leandro Marcelo Martinez, Norma Alejandra Chasseing, Vivian Labovsky, Erica Leonor Hofer, Hosoon Choi, Valeria Beatriz Fernández Vallone, Leonardo Feldman, Vincent La Russa, Emilio Batagelj, Daniela Caramutti, Federico Dimase
Publikováno v:
Clinicalexperimental metastasis. 30(3)
Tumour cells can find in bone marrow (BM) a niche rich in growth factors and cytokines that promote their self-renewal, proliferation and survival. In turn, tumour cells affect the homeostasis of the BM and bone, as well as the balance among haematop
Autor:
Raul H. Bordenave, Vincent F. La Russa, Erica Leonor Hofer, Norma Alejandra Chasseing, Eduardo Bullorsky, Alba Elizabeth Honegger
Previously, we reported a deficient cloning capacity of the bone marrow (BM) mesenchymal stem cells to give colony-forming unit fibroblast (CFU-F) and an inefficient confluence capacity of BM stromal cells in advanced untreated lung cancer patients (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47bc18c99c7cce23cb443a673027205e
http://online.liebertpub.com/doi/pdfplus/10.1089/scd.2005.14.587
http://online.liebertpub.com/doi/pdfplus/10.1089/scd.2005.14.587
Autor:
Raul H. Bordenave, Norma Alejandra Chasseing, Cesar G. Fraga, Eduardo O. Bullorsky, Erica Hofer, Elena M. V. de Cavanagh, Alba E. Honegger
Publikováno v:
Cancer. 94(12)
BACKGROUND Bone marrow (BM) is an important tissue in the generation of immunocompetent and peripheral blood cells. The precursors of hematopoietic cells in BM undergo continuous proliferation and differentiation and are highly vulnerable to acute an
Autor:
Raul H. Bordenave, Norma Alejandra Chasseing, Hosoon Choi, Valeria Beatriz Fernández Vallone, Leonardo Feldman, Federico Dimase, Leandro Martínez, Vivian Labovsky, Ana Rodriguez Villafañe, Vera Milovic, Gregorio Jaimovich, Emilio Batagelj
Publikováno v:
Blood. 122:4859-4859
It has been described that the hematopoietic niche has to be considered as a dynamic system that could easily behave as a tumor niche because they share many structural and functional components. Bone marrow (BM) mesenchymal stem cells (MSC) are one
Autor:
Raul H. Bordenave, Norma Alejandra Chasseing, Lia S. Rumi, Eduardo Bullorsky, Yolanda G. Trejo, Norma B. Diaz
Publikováno v:
Breast cancer research and treatment. 45(3)
Bone marrow fibroblast colony-forming cells (CFU-F) were studied in fifteen consecutive untreated breast cancer patients (BCP) with clinical stages III and IV, and in sixteen normal controls (NC). A decreased number of CFU-F was observed in BCP compa
Autor:
Raul H. Bordenave, Norma Alejandra Chasseing, Hosoon Choi, Federico Dimase, Leandro Martínez, Vivian Labovsky, Emilio Batagelj, Ana Rodriguez Villafañe, Valeria Beatriz Fernández Vallone, Leonardo Feldman
Publikováno v:
Cancer Research. 73:B66-B66
Bone metastasis is the major cause of death for advanced breast cancer patients (BCP). It is a multistep process that includes tumor cell mobilization, intravasation, survival in the circulation, extravasation and proliferation in bone marrow (BM) or